Anti-PCSK9 (Lodelcizumab)-SPDB-DM4 ADC

CAT:

708-ADC-W-1689

Size:

1 mg

Price:

Ask

For price, please contact [email protected]

Description: This ADC product is comprised of an anti-PCSK9 monoclonal antibody conjugated via a SPDB linker to DM4. The DM4 is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, DM1 binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
CAS Number: 9007-83-4
Format: Solution
Shipping Conditions: Ice Packs
Storage Conditions: -20°C

Cat	Name
ADC-W-1689	Anti-PCSK9 (Lodelcizumab)-SPDB-DM4 ADC
ADC-W-2229	Anti-PCSK9 (Bococizumab)-SPDB-DM4 ADC
ADC-W-1683	Anti-PCSK9 (Alirocumab)-SPDB-DM4 ADC
ADC-W-2313	Anti-PCSK9 (Ralpancizumab)-SPDB-DM4 ADC
ADC-W-2379	Anti-PCSK9 (Evolocumab)-SPDB-DM4 ADC
ADC-S-010	SPDB-DM4
ADC-W-1665	Anti-NGF -SPDB-DM4 ADC
ADC-W-2091	Anti-OxLDL-SPDB-DM4 ADC
ADC-W-474	Anti-MSLN-SPDB-DM4 ADC
ADC-W-1383	Anti-IL4R -SPDB-DM4 ADC